Welcome to our dedicated page for AMPHENOL /DE/ SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMPHENOL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMPHENOL /DE/'s regulatory disclosures and financial reporting.
Amphenol Corporation (APH) Form 144 notice reports a proposed sale of 113,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $12,304,750.80 and an approximate sale date of 08/08/2025. The shares were acquired on 08/08/2025 by exercising options under a registered plan and were to be paid in cash. The filing records total shares outstanding of 1,220,921,111 for the issuer. The document also discloses a prior sale of 160,000 shares on 05/30/2025 that generated gross proceeds of $14,326,512.00. The seller affirms no knowledge of undisclosed material adverse information.